Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (531-540 of 564) with videos related to

Pageof 57
Sort By:
European Journal of Clinical Pharmacology|January 1, 1986
Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flowJ Biollaz, B Waeber, J Nussberger, et al.
Schweizerische Medizinische Wochenschrift|March 25, 1989
[Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy]C Beretta-Piccoli, R Amstein, F R Bühler, et al.
The American Journal of Cardiology|April 1, 1985
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failureP Nicod, B Waeber, J P Bussien, et al.
Schweizerische Medizinische Wochenschrift|December 14, 1985
[Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]P Nicod, J Goy, B Waeber, et al.
Acta Endocrinologica|June 1, 1986
Haemodynamic role of vasopressin released during Finnish saunaJ P Bussien, R C Gaillard, J Nussberger, et al.
Journal of Cardiovascular Pharmacology|May 1, 1989
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndromeM Burnier, V Mooser, J P Wauters, et al.
The American Journal of Physiology|June 1, 1993
Spontaneous diameter oscillations of the radial artery in humansD Hayoz, Y Tardy, B Rutschmann, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.
European Journal of Clinical Pharmacology|January 1, 1984
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteersM D Schaller, D B Brunner, J Nussberger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1985
The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteersJ P Bussien, J Nussberger, M Porchet, et al.
Pageof 57

Showing results (531-540 of 564) with videos related to

Sort By:
Pageof 57
European Journal of Clinical Pharmacology|January 1, 1986
Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flowJ Biollaz, B Waeber, J Nussberger, et al.
Schweizerische Medizinische Wochenschrift|March 25, 1989
[Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy]C Beretta-Piccoli, R Amstein, F R Bühler, et al.
The American Journal of Cardiology|April 1, 1985
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failureP Nicod, B Waeber, J P Bussien, et al.
Schweizerische Medizinische Wochenschrift|December 14, 1985
[Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]P Nicod, J Goy, B Waeber, et al.
Acta Endocrinologica|June 1, 1986
Haemodynamic role of vasopressin released during Finnish saunaJ P Bussien, R C Gaillard, J Nussberger, et al.
Journal of Cardiovascular Pharmacology|May 1, 1989
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndromeM Burnier, V Mooser, J P Wauters, et al.
The American Journal of Physiology|June 1, 1993
Spontaneous diameter oscillations of the radial artery in humansD Hayoz, Y Tardy, B Rutschmann, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.
European Journal of Clinical Pharmacology|January 1, 1984
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteersM D Schaller, D B Brunner, J Nussberger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1985
The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteersJ P Bussien, J Nussberger, M Porchet, et al.
Pageof 57